Here's the current landscape: Brand Name Oral Semaglutide (Wegovy pill): Novo Nordisk announced a limited-time price of $149/month for the starting dose Higher doses (25mg) may cost more Launched in January 2026 Additional costs may apply such as labs, consultations, shipping and membership Brand Name Injectable GLP-1s: Wegovy: $1,000-1,500/month without insurance Ozempic: $900-1,000/month without insurance Mounjaro/Zepbound: $1,000-1,400/month without insurance Compounded Injectable GLP-1s: Affinity Whole Health: Starting at $299/month for compounded semaglutide Includes medications, supplies, shipping, and ongoing support Significant savings compared to brand names Compounded ODT Formulations: Prices vary widely, typically $299-449/month for compounded semaglutide or tirzepatide ODTs Generally more expensive than compounded injectables Available through compounding pharmacies Currently, compounded injectable medications from FDA-registered facilities remain the most cost-effective option for most patients seeking GLP-1 therapy

Key Takeaways GLP-1 medications mimic natural hormones that help regulate appetite, insulin production, and blood sugar levels, making them effective for managing type 2 diabetes and supporting weight loss
There are some factors that you may want to take into considering when deciding if a GLP-1 medication is right for you: Your overall health Your family history with certain conditions Potential side-effects of GLP-1 medications Your treatment goals Your budget and insurance coverage Will I Lose Weight from a GLP-1 Medicine Alone
Be thorough and honest on your intake form about all current medications and supplements
Diabetes 54 , 13921399 (2005)